The Sirtuin 2 Inhibitor AK-7 Is Neuroprotective in Huntington’s Disease Mouse Models
Open Access
- 27 December 2012
- journal article
- research article
- Published by Elsevier BV in Cell Reports
- Vol. 2 (6), 1492-1497
- https://doi.org/10.1016/j.celrep.2012.11.001
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Selective histone deacetylase (HDAC) inhibition imparts beneficial effects in Huntington's disease mice: implications for the ubiquitin–proteasomal and autophagy systemsHuman Molecular Genetics, 2012
- 3-(N-Arylsulfamoyl)benzamides, inhibitors of human sirtuin type 2 (SIRT2)Bioorganic & Medicinal Chemistry Letters, 2012
- SIRT2 Ablation Has No Effect on Tubulin Acetylation in Brain, Cholesterol Biosynthesis or the Progression of Huntington's Disease Phenotypes In VivoPLOS ONE, 2012
- Sir-two-homolog 2 (Sirt2) modulates peripheral myelination through polarity protein Par-3/atypical protein kinase C (aPKC) signalingProceedings of the National Academy of Sciences of the United States of America, 2011
- Sirt2 is a novel in vivo downstream target of Nkx2.2 and enhances oligodendroglial cell differentiationJournal of Molecular Cell Biology, 2011
- Aging and disease: connections to sirtuinsAging Cell, 2010
- Neuroprotection for Huntington’s disease: Ready, set, slowNeurotherapeutics, 2008
- A small-molecule therapeutic lead for Huntington's disease: Preclinical pharmacology and efficacy of C2-8 in the R6/2 transgenic mouseProceedings of the National Academy of Sciences of the United States of America, 2007
- Appearances can be deceiving: phenotypes of knockout miceBriefings in Functional Genomics and Proteomics, 2007
- A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomesCell, 1993